在癌症中,催化转换会影响饮食干预
1Department of Biochemistry, Semmelweis University, Budapest, Hungary. chinopoulos.christos@semmelweis.hu.
Communications biology
|December 7, 2025
概括
饮食改变可以通过改变瘤代谢和减少炎症来帮助抗击癌症. 虽然这种方法并不能完全消除瘤,但与传统的癌症治疗相比,这种方法具有显著的好处.
科学领域:
- 在瘤学瘤学.
- 代谢研究的研究.
- 营养科学 营养科学
背景情况:
- 癌细胞与胚胎组织具有代谢相似性,具有治疗点.
- 饮食修改是作为对抗瘤的策略而被探索的.
- 由于瘤的适应性,充分利用饮食来治疗癌症存在挑战.
研究的目的:
- 审查癌细胞如何利用大分子获得能量.
- 评估通过饮食影响癌细胞代谢的可行性.
- 探索癌症治疗中饮食干预措施的辅助益处.
主要方法:
- 关于癌细胞代谢的文献综述.
- 在瘤中对宏分子的获取和代谢的分析.
- 评估饮食干预对瘤能量和宿主生理学的影响.
主要成果:
- 癌细胞表现出高代谢需求,类似于增殖组织.
- 饮食干预对瘤基质供应有有限的直接影响.
- 饮食改变诱导有益的荷尔蒙状态,增强免疫反应,减少炎症.
结论:
- 饮食干预措施通过调节宿主新陈代谢和免疫力,在癌症治疗中提供支持性益处.
- 将营养纳入标准癌症护理是一个有前途的辅助策略.
- 虽然通过饮食直接饥饿瘤是一个挑战,但间接的好处是显著的.
相关概念视频
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Overview of Protein Metabolism
3.6K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
3.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


